Cell death in a co‑culture of hepatocellular carcinoma cells and human umbilical vascular endothelial cells in a medium lacking glucose and arginine

Tomizawa,Minoru; Shinozaki,Fuminobu; Motoyoshi,Yasufumi; Sugiyama,Takao; Yamamoto,Shigenori; Ishige,Naoki

doi:10.3892/ol.2016.5454

Cell death in a co‑culture of hepatocellular carcinoma cells and human umbilical vascular endothelial cells in a medium lacking glucose and arginine

Authors:
- Minoru Tomizawa
- Fuminobu Shinozaki
- Yasufumi Motoyoshi
- Takao Sugiyama
- Shigenori Yamamoto
- Naoki Ishige
View Affiliations

Affiliations: Department of Gastroenterology, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan, Department of Radiology, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan, Department of Neurosurgery, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan, Department of Rheumatology, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan, Department of Pediatrics, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan, Department of Internal Medicine, National Hospital Organization Shimoshizu Hospital, Yotsukaido, Chiba 284‑0003, Japan
Published online on: November 30, 2016 https://doi.org/10.3892/ol.2016.5454
Pages: 258-262

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Human primary hepatocytes are able to survive in a medium without glucose and arginine that is instead supplemented with galactose and ornithine (hepatocyte selection medium; HSM). This is because the cells produce glucose and arginine by the action of galactokinase (GALK) and ornithine carbamoyltransferase (OTC), respectively. It was expected that hepatocellular carcinoma (HCC) cells do not survive in HSM. In the current study, HCC cell lines (namely HLE, HLF, PLC/PRL/5, Hep3B and HepG2) and human umbilical vascular endothelial cells (HUVECs) were cultured in HSM, and the expression levels of GALK1, GALK2 and OTC were analyzed by reverse transcription‑quantitative polymerase chain reaction. HLE, HLF and PLC/PRL/5 cells died on day 11, while Hep3B, HepG2 and HUVECs died on day 7. HLF cells were further analyzed as these cells had lower expression levels of GALK1, GALK2 and OTC compared with adult liver cells, and survived until day 11. In these cells, the expression levels of GALK1, GALK2 and OTC did not change on days 3 and 7 as compared to day 0. In addition, a co‑culture of HLF cells with HUVECs was established and the medium was changed to HSM. It was observed that HLF cells and HUVECs in co‑culture were damaged in HSM. In summary, HCC cells and HUVECs died in a medium without glucose and arginine that was supplemented with galactose and ornithine. HCC cells and HUVECs were damaged in HSM, suggesting a potential application for treatment with the medium.

View Figures

View References

1	Zhu RX, Seto WK, Lai CL and Yuen MF: Epidemiology of hepatocellular carcinoma in the Asia-Pacific region. Gut Liver. 10:332–339. 2016. View Article : Google Scholar : PubMed/NCBI
2	Tomizawa M, Kondo F and Kondo Y: Growth patterns and interstitial invasion of small hepatocellular carcinoma. Pathol Int. 45:352–358. 1995. View Article : Google Scholar : PubMed/NCBI
3	Lencioni R, Petruzzi P and Crocetti L: Chemoembolization of hepatocellular carcinoma. Semin Intervent Radiol. 30:3–11. 2013. View Article : Google Scholar : PubMed/NCBI
4	Kim HY and Park JW: Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: Past, present and future. Liver Cancer. 3:9–17. 2014. View Article : Google Scholar : PubMed/NCBI
5	Raoul JL, Gilabert M and Piana G: How to define transarterial chemoembolization failure or refractoriness: A European perspective. Liver Cancer. 3:119–124. 2014. View Article : Google Scholar : PubMed/NCBI
6	Leffert HL and Paul D: Studies on primary cultures of differentiated fetal liver cells. J Cell Biol. 52:559–568. 1972. View Article : Google Scholar : PubMed/NCBI
7	Matsumoto K, Yamada K, Kohmura E, Kinoshita A and Hayakawa T: Role of pyruvate in ischaemia-like conditions on cultured neurons. Neurol Res. 16:460–464. 1994. View Article : Google Scholar : PubMed/NCBI
8	Ohira RH, Dipple KM, Zhang YH and McCabe ER: Human and murine glycerol kinase: Influence of exon 18 alternative splicing on function. Biochem Biophys Res Commun. 331:239–246. 2005. View Article : Google Scholar : PubMed/NCBI
9	Ai Y, Jenkins NA, Copeland NG, Gilbert DH, Bergsma DJ and Stambolian D: Mouse galactokinase: Isolation, characterization and location on chromosome 11. Genome Res. 5:53–59. 1995. View Article : Google Scholar : PubMed/NCBI
10	Phillips JW, Jones ME and Berry MN: Implications of the simultaneous occurrence of hepatic glycolysis from glucose and gluconeogenesis from glycerol. Eur J Biochem. 269:792–797. 2002. View Article : Google Scholar : PubMed/NCBI
11	Sumida KD, Crandall SC, Chadha PL and Qureshi T: Hepatic gluconeogenic capacity from various precursors in young versus old rats. Metabolism. 51:876–880. 2002. View Article : Google Scholar : PubMed/NCBI
12	Wheatley DN, Scott L, Lamb J and Smith S: Single amino acid (arginine) restriction: Growth and death of cultured HeLa and human diploid fibroblasts. Cell Physiol Biochem. 10:37–55. 2000. View Article : Google Scholar : PubMed/NCBI
13	Walker V: Ammonia toxicity and its prevention in inherited defects of the urea cycle. Diabetes Obes Metab. 11:823–835. 2009. View Article : Google Scholar : PubMed/NCBI
14	Tomizawa M, Toyama Y, Ito C, Toshimori K, Iwase K, Takiguchi M, Saisho H and Yokosuka O: Hepatoblast-like cells enriched from mouse embryonic stem cells in medium without glucose, pyruvate, arginine and tyrosine. Cell Tissue Res. 333:17–27. 2008. View Article : Google Scholar : PubMed/NCBI
15	Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M and Yoshida T: Survival of primary human hepatocytes and death of induced pluripotent stem cells in media lacking glucose and arginine. PLoS One. 8:e718972013. View Article : Google Scholar : PubMed/NCBI
16	Nakamura T, Teramoto H, Tomita Y and Ichihara A: L-proline is an essential amino acid for hepatocyte growth in culture. Biochem Biophys Res Commun. 122:884–891. 1984. View Article : Google Scholar : PubMed/NCBI
17	Davies B and Fried M: The L19 ribosomal protein gene (RPL19): Gene organization, chromosomal mapping, and novel promoter region. Genomics. 25:372–380. 1995. View Article : Google Scholar : PubMed/NCBI
18	Tam S, Clavijo A, Engelhard EK and Thurmond MC: Fluorescence-based multiplex real-time RT-PCR arrays for the detection and serotype determination of foot-and-mouth disease virus. J Virol Methods. 161:183–191. 2009. View Article : Google Scholar : PubMed/NCBI
19	Simons AL, Mattson DM, Dornfeld K and Spitz DR: Glucose deprivation-induced metabolic oxidative stress and cancer therapy. J Cancer Res Ther. 5:(Suppl 1). S2–S6. 2009. View Article : Google Scholar : PubMed/NCBI
20	Módis K, Gerő D, Stangl R, Rosero O, Szijártó A, Lotz G, Mohácsik P, Szoleczky P, Coletta C and Szabó C: Adenosine and inosine exert cytoprotective effects in an in vitro model of liver ischemia-reperfusion injury. Int J Mol Med. 31:437–446. 2013.PubMed/NCBI
21	Cai H, Jiang D, Qi F, Xu J, Yu L and Xiao Q: HRP-3 protects the hepatoma cells from glucose deprivation-induced apoptosis. Int J Clin Exp Pathol. 8:14383–14391. 2015.PubMed/NCBI
22	Feun L, You M, Wu CJ, Kuo MT, Wangpaichitr M, Spector S and Savaraj N: Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des. 14:1049–1057. 2008. View Article : Google Scholar : PubMed/NCBI
23	Ju W, Li S, Wang Z, Liu Y and Wang D: Decorin protects human hepatocma HepG2 cells against oxygen-glucose deprivation via modulating autophagy. Int J Clin Exp Med. 8:13347–13452. 2015.PubMed/NCBI